Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 119,700 | 80,200 | -12,500 | 54,500 | 7,600 |
| Depreciation Amortization | 88,000 | 58,300 | 28,900 | 113,700 | 85,000 |
| Income taxes - deferred | -4,400 | -3,700 | -4,200 | -1,100 | -5,700 |
| Accounts receivable | 74,600 | 12,100 | 108,200 | -8,200 | -18,600 |
| Accounts payable and accrued liabilities | 10,600 | -14,500 | -15,600 | 16,500 | 2,500 |
| Other Working Capital | -14,300 | -11,400 | 38,400 | -58,400 | -74,200 |
| Other Operating Activity | 16,700 | 64,700 | -85,400 | 71,000 | 69,300 |
| Operating Cash Flow | $290,900 | $185,700 | $57,800 | $188,000 | $65,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -105,000 | -59,300 | -24,200 | -86,900 | -50,800 |
| Other Investing Activity | -10,000 | -10,000 | 0 | -10,000 | -10,000 |
| Investing Cash Flow | $-115,000 | $-69,300 | $-24,200 | $-96,900 | $-60,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 441,600 | N/A | N/A | 118,700 | 130,000 |
| Debt Repayment | -373,000 | -25,600 | -22,800 | -105,000 | -103,400 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 5,700 |
| Other Financing Activity | 3,200 | 10,300 | 2,800 | -49,600 | -10,300 |
| Financing Cash Flow | $71,800 | $-15,300 | $-20,000 | $-35,900 | $22,000 |
| Exchange Rate Effect | -500 | -100 | 100 | 400 | -100 |
| Beginning Cash Position | 168,000 | 168,000 | 168,000 | 112,400 | 112,400 |
| End Cash Position | 415,200 | 269,000 | 181,700 | 168,000 | 139,400 |
| Net Cash Flow | $247,200 | $101,000 | $13,700 | $55,600 | $27,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 290,900 | 185,700 | 57,800 | 188,000 | 65,900 |
| Capital Expenditure | -105,000 | -59,300 | -24,200 | -86,900 | -50,800 |
| Free Cash Flow | 185,900 | 126,400 | 33,600 | 101,100 | 15,100 |